Three firms act on deals between DASA and Amil
Stocche Forbes and BMA advised Diagnósticos da América (DASA) on the business combination of hospitals and oncology clinics with Amil Assistência Médica Internacional (Amil), which was advised by Lefosse.
The transaction involved the contribution, to Ímpar Serviços Hospitalares (Ímpar), Dasa’s hospital and oncology company, by Amil of 11 hospitals and 1.6 thousand beds.
Combined net revenues from the operations included in the transaction amounted to R$9.9 billion in 2023 (R$5.7 billion from Dasa assets and R$4.2 billion from Amil assets), with an estimated EBITDA of R$777 million (R$600 million from Dasa assets and R$177 million from Amil assets).
Stocche Forbes advised DASA and relied on partners Guilherme Forbes, Fabiano Milani, Ricardo Freoa, Rafael Andrade, Igor Finzi and Matheus Campos (pictured top from left to right), associates André Penna Bandeira de Mello, Luis Filipe Ferreira da Costa, Carolina Vilela Marcondes Machado and Pedro Rocha Ferreira.
BMA Advogados also advised Diagnósticos da América (DASA) and relied on partners Luiz Antonio de Sampaio Campos, Felipe Guimarães Rosa Bon, Henrique Vargas Beloch, Jose Otavio Haddad Faloppa, Conrado de Castro Stievani and Gabriel Bürgel.
Lefosse advised Amil and relied on partners Carlos Mello, Laura Affonso and Leonardo Batista (pictured bottom from left to right), associates Luana Torres, João Pedro Pizarro, Lucas Queiroz, Raquel Dotta, Douglas Fukuhara, Vinicius Salvino and Luiza Mendonça.
In-house counsel
DASA: Nelcina Tropardi, Renata Rodrigues Bruno Borba e Diego Osório
Amil: Fabian Rocha.
